Kimberly-Clark Corporation $KMB Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lessened its position in Kimberly-Clark Corporation (NASDAQ:KMB) by 4.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 737,861 shares of the company’s stock after selling 31,602 shares during the period. Sumitomo Mitsui Trust Group Inc. owned about 0.22% of Kimberly-Clark worth $71,890,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of KMB. Mystic Asset Management Inc. grew its position in shares of Kimberly-Clark by 0.5% during the 3rd quarter. Mystic Asset Management Inc. now owns 20,354 shares of the company’s stock worth $1,983,000 after buying an additional 109 shares during the period. Assetmark Inc. boosted its position in Kimberly-Clark by 0.6% during the 1st quarter. Assetmark Inc. now owns 20,216 shares of the company’s stock worth $1,950,000 after acquiring an additional 121 shares during the last quarter. Annex Advisory Services LLC lifted its position in Kimberly-Clark by 2.0% during the 3rd quarter. Annex Advisory Services LLC now owns 6,533 shares of the company’s stock worth $637,000 after buying an additional 125 shares in the last quarter. Root Financial Partners LLC boosted its holdings in shares of Kimberly-Clark by 17.6% in the 1st quarter. Root Financial Partners LLC now owns 847 shares of the company’s stock valued at $82,000 after buying an additional 127 shares during the last quarter. Finally, Modera Wealth Management LLC increased its stake in shares of Kimberly-Clark by 3.9% during the 3rd quarter. Modera Wealth Management LLC now owns 3,414 shares of the company’s stock worth $333,000 after purchasing an additional 129 shares during the last quarter. 76.29% of the stock is currently owned by institutional investors and hedge funds.

More Kimberly-Clark News

Here are the key news stories impacting Kimberly-Clark this week:

• Positive Sentiment: Kimberly-Clark completed its acquisition of Kenvue, adding a broad consumer-health portfolio that includes 10 billion-dollar brands. The company reiterated expected annual run-rate synergies of $2.1 billion, offering potential for longer-term growth and cost savings. Read More.
• Neutral Sentiment: The acquisition is now closed, shifting investor focus from deal completion to integration, synergy delivery, and the combined company’s financial performance. KMB’s Q3 results are due November 5. Read More.
• Negative Sentiment: The transaction is substantial: its enterprise value was reported at nearly $49 billion. Kimberly-Clark also announced exchange offers involving up to $7 billion of new company notes, raising investor focus on financing and the added debt burden as it integrates Kenvue. Read More. Read More.
• Negative Sentiment: Analyst previews warn that weak consumer spending and rising costs could weigh on Q3 results, although product innovation and efficiency gains may provide some support. That uncertainty may limit enthusiasm ahead of the earnings report. Read More.

Kimberly-Clark Stock Performance

Shares of KMB stock opened at $104.46 on Wednesday. Kimberly-Clark Corporation has a one year low of $92.42 and a one year high of $116.82. The company has a debt-to-equity ratio of 3.45, a current ratio of 0.91 and a quick ratio of 0.69. The business’s 50 day simple moving average is $102.66 and its 200 day simple moving average is $103.09. The stock has a market capitalization of $34.74 billion, a PE ratio of 17.77, a PEG ratio of 5.85 and a beta of 0.25.

Kimberly-Clark (NASDAQ:KMB) last released its earnings results on Tuesday, August 4th. The company reported $1.80 EPS for the quarter, missing the consensus estimate of $2.01 by ($0.21). The business had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.22 billion. Kimberly-Clark had a return on equity of 143.92% and a net margin of 11.79%. The company’s revenue for the quarter was up .6% on a year-over-year basis. During the same period in the prior year, the business earned $1.92 EPS. As a group, research analysts forecast that Kimberly-Clark Corporation will post 6.83 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on KMB shares. Bank of America reduced their price objective on Kimberly-Clark from $122.00 to $120.00 and set a “buy” rating for the company in a report on Friday, September 25th. Rothschild & Co Redburn cut their target price on Kimberly-Clark from $138.00 to $129.00 and set a “buy” rating for the company in a research report on Friday, October 9th. Canaccord Genuity Group initiated coverage on Kimberly-Clark in a report on Friday, October 23rd. They set a “hold” rating and a $105.00 target price on the stock. Wells Fargo & Company dropped their target price on shares of Kimberly-Clark from $105.00 to $100.00 and set an “equal weight” rating for the company in a research report on Monday, October 5th. Finally, Seaport Research Partners upgraded Kimberly-Clark to a “buy” rating in a research report on Tuesday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Kimberly-Clark currently has an average rating of “Hold” and a consensus price target of $110.67.

About Kimberly-Clark

Kimberly-Clark Corporation (NASDAQ:KMB) is a global consumer products company that develops and markets personal care, tissue and professional hygiene products. Its portfolio includes products for babies and children, feminine care, adult care, family care and workplace hygiene.

The company’s well-known brands include Huggies diapers and wipes, Kleenex facial tissue, Cottonelle bathroom tissue, Scott toilet paper and paper towels, Kotex feminine care products, and Depend, Poise and GoodNites products.